Back to Search
ELIZABETH SHPALL, M.D.
M.D.
Medical Oncology Physician
NPI: 1326139098IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L5561(TX)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
Class of 1980
Research & Publications (20)
Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.
PMID 18480841·J Invest Dermatol·2008
8-other
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
PMID 19668237·Bone Marrow Transplant·2010
3-trial
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.
PMID 19443656·Blood·2009
8-other
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
PMID 19144658·Haematologica·2009
8-other
High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?
PMID 19532017·Curr Opin Oncol·2009
6-review
De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination.
PMID 19185049·Vaccine·2009
8-other
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
PMID 19654407·Blood·2009
8-other
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
PMID 19539208·Biol Blood Marrow Transplant·2009
6-review
Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.
PMID 19171878·Blood·2009
4-observational
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
PMID 19235255·Cancer·2009
8-other
Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT.
PMID 19029968·Bone Marrow Transplant·2009
5-case
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
PMID 19450756·Biol Blood Marrow Transplant·2009
8-other
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells.
PMID 19544439·Stem Cells·2009
7-preclinical
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
PMID 18209724·Bone Marrow Transplant·2008
3-trial
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
PMID 18489993·Biol Blood Marrow Transplant·2008
3-trial
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.
PMID 18413766·Cancer Res·2008
8-other
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
PMID 17989720·Leukemia·2008
3-trial
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.
PMID 18640568·Biol Blood Marrow Transplant·2008
8-other
Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005.
PMID 18004177·Medicine (Baltimore)·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1326139098
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile